Skip to content
OpenCapital
Get started

Artelo Biosciences ARTL Q1 2026 earnings

Reported May 14, 2026 · Before market open

EPS-$4.00Miss by $3.22
EPS estimate-$0.78

Next report

Aug 12, 2026 (In 2 weeks)
EPS estimate-$0.72

Versus estimates

Diluted EPS

Q1 2026-$4.00Miss by $3.22
Q4 2025-$6.66Miss by $1.95Q3 2025-$3.97Miss by $3.15Q2 2025-$5.61Miss by $1.42Q1 2025-$4.32Miss by $3.52Q4 2024-$7.02Miss by $4.40

Ask the moment Artelo Biosciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Artelo Biosciences report Q1 2026 earnings?
Artelo Biosciences (ARTL) reported Q1 2026 earnings on May 14, 2026 before market open.
What were Artelo Biosciences's Q1 2026 revenue and EPS?
Artelo Biosciences reported eps of $-4.00 for Q1 2026.
Did Artelo Biosciences beat estimates in Q1 2026?
EPS missed the consensus estimate of $-0.78 by $3.22.
How did Artelo Biosciences's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 7.4% from $-4.32.
Where can I find Artelo Biosciences's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001640334-26-000903) and the 10-Q periodic report (0001640334-26-000869) directly on SEC EDGAR. The filing index links above go to sec.gov.